Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

OSTX OS Therapies Inc

Price (delayed)

$1.66

Market cap

$46.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.86

Enterprise value

$43.67M

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address ...

Highlights
OS Therapies's debt has plunged by 100% YoY
The EPS has surged by 56% year-on-year and by 2.3% since the previous quarter
The equity has surged by 84% year-on-year but it has declined by 28% since the previous quarter
OS Therapies's net income has plunged by 53% YoY and by 27% from the previous quarter
The quick ratio has decreased by 30% QoQ

Key stats

What are the main financial stats of OSTX
Market
Shares outstanding
28.1M
Market cap
$46.64M
Enterprise value
$43.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$11.18M
Net income
-$11.3M
EBIT
-$10.08M
EBITDA
-$10.07M
Free cash flow
-$10.08M
Per share
EPS
-$0.86
EPS diluted
-$0.86
Free cash flow per share
-$0.47
Book value per share
-$0.19
Revenue per share
$0
TBVPS
$0.2
Balance sheet
Total assets
$4.25M
Total liabilities
$3.64M
Debt
$0
Equity
-$4.19M
Working capital
$559,091
Liquidity
Debt to equity
0
Current ratio
1.16
Quick ratio
0.84
Net debt/EBITDA
0.29
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-405%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-1,412.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OSTX stock price

How has the OS Therapies stock price performed over time
Intraday
4.4%
1 week
-2.35%
1 month
-18.63%
1 year
N/A
YTD
-61.21%
QTD
7.79%

Financial performance

How have OS Therapies's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.18M
Net income
-$11.3M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 185% YoY and by 64% from the previous quarter
OS Therapies's net income has plunged by 53% YoY and by 27% from the previous quarter

Price vs fundamentals

How does OSTX's price correlate with its fundamentals

Growth

What is OS Therapies's growth rate over time

Valuation

What is OS Therapies stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 56% year-on-year and by 2.3% since the previous quarter
The equity has surged by 84% year-on-year but it has declined by 28% since the previous quarter

Efficiency

How efficient is OS Therapies business performance
The ROA has grown by 44% YoY and by 8% from the previous quarter

Dividends

What is OSTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OSTX.

Financial health

How did OS Therapies financials performed over time
OS Therapies's total assets is 17% higher than its total liabilities
The total liabilities has plunged by 86% YoY and by 23% from the previous quarter
The quick ratio has decreased by 30% QoQ
OS Therapies's debt is 100% more than its equity
OS Therapies's debt has plunged by 100% YoY
OS Therapies's debt to equity has soared by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.